Long-term progestin therapy for female chronic respiratory insufficiency?

Respir Med. 2004 Feb;98(2):194-5. doi: 10.1016/j.rmed.2003.09.008.

Abstract

End-stage chronic obstructive pulmonary disease often leads to hypercapnic respiratory failure. Oxygen supplementation therapy may further aggravate hypercapnia and not all patients are compliant with non-invasive ventilation. This case documents successful control of chronic respiratory failure with medroxyprogesterone in a postmenopausal woman during 1-year follow-up.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Chronic Disease
  • Female
  • Follow-Up Studies
  • Humans
  • Long-Term Care
  • Medroxyprogesterone Acetate / therapeutic use*
  • Respiratory Insufficiency / drug therapy*
  • Respiratory System Agents / therapeutic use*

Substances

  • Respiratory System Agents
  • Medroxyprogesterone Acetate